Literature DB >> 12466268

Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Pascal Schneider1, Dian Olson, Aubry Tardivel, Beth Browning, Alexey Lugovskoy, DaHai Gong, Max Dobles, Sylvie Hertig, Kay Hofmann, Herman Van Vlijmen, Yen-Ming Hsu, Linda C Burkly, Jurg Tschopp, Timothy S Zheng.   

Abstract

Tumor necrosis factor (TNF) ligand and receptor superfamily members play critical roles in diverse developmental and pathological settings. In search for novel TNF superfamily members, we identified a murine chromosomal locus that contains three new TNF receptor-related genes. Sequence alignments suggest that the ligand binding regions of these murine TNF receptor homologues, mTNFRH1, -2 and -3, are most homologous to those of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors. By using a number of in vitro ligand-receptor binding assays, we demonstrate that mTNFRH1 and -2, but not mTNFRH3, bind murine TRAIL, suggesting that they are indeed TRAIL receptors. This notion is further supported by our demonstration that both mTNFRH1:Fc and mTNFRH2:Fc fusion proteins inhibited mTRAIL-induced apoptosis of Jurkat cells. Unlike the only other known murine TRAIL receptor mTRAILR2, however, neither mTNFRH2 nor mTNFRH3 has a cytoplasmic region containing the well characterized death domain motif. Coupled with our observation that overexpression of mTNFRH1 and -2 in 293T cells neither induces apoptosis nor triggers NFkappaB activation, we propose that the mTnfrh1 and mTnfrh2 genes encode the first described murine decoy receptors for TRAIL, and we renamed them mDcTrailr1 and -r2, respectively. Interestingly, the overall sequence structures of mDcTRAILR1 and -R2 are quite distinct from those of the known human decoy TRAIL receptors, suggesting that the presence of TRAIL decoy receptors represents a more recent evolutionary event.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466268     DOI: 10.1074/jbc.M210783200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  Resistance to TRAIL and how to surmount it.

Authors:  Danijela Maksimovic-Ivanic; Stanislava Stosic-Grujicic; Ferdinando Nicoletti; Sanja Mijatovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  A genomic reservoir for Tnfrsf genes is developmentally regulated and imprinted in the mouse.

Authors:  Elena de la Casa Esperón; Gaëlle Cordier; Nora Engel
Journal:  Epigenetics       Date:  2012-06-01       Impact factor: 4.528

3.  Preclinical studies of a death receptor 5 fusion protein that ameliorates acute liver failure.

Authors:  Qian Chen; Pu Wang; Qingmei Zhang; Meng Xia; Guizhong Zhang; Junxin Li; Enyun Shen; Youhai H Chen; Xiaochun Wan
Journal:  J Mol Med (Berl)       Date:  2019-06-22       Impact factor: 4.599

4.  Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies.

Authors:  E W Duiker; E C F Dijkers; H Lambers Heerspink; S de Jong; A G J van der Zee; P L Jager; J G W Kosterink; E G E de Vries; M N Lub-de Hooge
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt.

Authors:  Laurel A Grisanti; Jennifer A Talarico; Rhonda L Carter; Justine E Yu; Ashley A Repas; Scott W Radcliffe; Hoang-Ai Tang; Catherine A Makarewich; Steven R Houser; Douglas G Tilley
Journal:  J Mol Cell Cardiol       Date:  2014-02-22       Impact factor: 5.000

6.  Tumor necrosis factor-related apoptosis-inducing ligand mediates the resolution of allergic airway inflammation induced by chronic allergen inhalation.

Authors:  L Faustino; D M Fonseca; E B Florsheim; R R Resende; A P Lepique; E Faquim-Mauro; E Gomes; J S Silva; H Yagita; M Russo
Journal:  Mucosal Immunol       Date:  2014-02-26       Impact factor: 7.313

7.  Evolution of the Beckwith-Wiedemann syndrome region in vertebrates.

Authors:  Martina Paulsen; Tarang Khare; Christopher Burgard; Sascha Tierling; Jörn Walter
Journal:  Genome Res       Date:  2004-12-08       Impact factor: 9.043

8.  Muscle-derived TRAIL negatively regulates myogenic differentiation.

Authors:  Dongwook Kim; Nilmani Singh; Rachel J Waldemer-Streyer; Mee-Sup Yoon; Jie Chen
Journal:  Exp Cell Res       Date:  2020-07-06       Impact factor: 3.905

Review 9.  Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.

Authors:  Bharat B Aggarwal; Subash C Gupta; Ji Hye Kim
Journal:  Blood       Date:  2011-11-03       Impact factor: 22.113

Review 10.  Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy.

Authors:  Pedro P G Guimarães; Stephanie Gaglione; Tomasz Sewastianik; Ruben D Carrasco; Robert Langer; Michael J Mitchell
Journal:  ACS Nano       Date:  2018-02-06       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.